Thinking about how organisations perform in an AI-enabled world

AyEye Today · 28 October 2026

AI can fill the queue. Reality still has to decide

Abstract painting of quick blue and yellow-green marks driven into a dense red-grey impasto field that smears and transforms them.
Original artwork: The World Pushes Back. Chiappe × OpenAI.

Genie 4 and AI-assisted drug programmes can multiply plausible candidates. The advantage moves to organisations that can test them honestly.

The story, brieflyEvidence · Interpretation

The argument

When generated candidates outpace trustworthy tests, advantage shifts towards organisations that can make proposals collide with independent evidence.

What is new

Genie 4 creates short steerable audiovisual worlds. Anthropic’s partners report AI-assisted designs entering laboratory loops, including tens of thousands of antibody candidates.

Why it matters

Laboratories, controlled pilots and expert attention remain scarce. The decisive capability is choosing tests that expose mistaken assumptions rather than reward plausible demonstrations.

LecXie’s practical interpretation

Preserve candidate lineage, select experiments for information, separate maker and judge, reserve physical capacity and publish the transfer gap.

Evidence & limits

Genie 4 remains a trusted-tester preview. Anthropic’s reports are mostly preclinical collaborations and cannot isolate Claude’s contribution from people, laboratories and data systems.